Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias

Autor: Andrejko, Kristin L, Pry, Jake M, Myers, Jennifer F, Mehrotra, Megha, Lamba, Katherine, Lim, Esther, Fukui, Nozomi, DeGuzman, Jennifer L, Openshaw, John, Watt, James, Jain, Seema, Lewnard, Joseph A, Covid-Case-Control Study Team, On Behalf Of The California

Publikováno v: American journal of epidemiology, vol 192, iss 6

Concerns about the duration of protection conferred by coronavirus disease 2019 (COVID-19) vaccines have arisen in postlicensure evaluations. "Depletion of susceptibles," a bias driven by differential accrual of infection among vaccinated and unvacci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::7d0a65032dd021f9fcb797239b353c85
https://escholarship.org/uc/item/3n16w70q

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure

Autor: Andrejko, Kristin L, Pry, Jake, Myers, Jennifer F, Openshaw, John, Watt, James, Birkett, Nozomi, DeGuzman, Jennifer L, Barbaduomo, Camilla M, Dong, Zheng N, Fang, Anna T, Frost, Paulina M, Ho, Timothy, Javadi, Mahsa H, Li, Sophia S, Tran, Vivian H, Wan, Christine, Jain, Seema, Lewnard, Joseph A, California COVID-19 Case-Control Study Team

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 75, iss 1

BackgroundNon-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified.MethodsWe conducted a test-negative design case-control stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::594a83aeaa71cc5aebf98063683115fa
https://escholarship.org/uc/item/0k72k1t1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure.

Autor: Andrejko KL; Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, USA., Pry J; California Department of Public Health, Richmond, California, USA., Myers JF; California Department of Public Health, Richmond, California, USA., Openshaw J; California Department of Public Health, Richmond, California, USA., Watt J; California Department of Public Health, Richmond, California, USA., Birkett N; California Department of Public Health, Richmond, California, USA., DeGuzman JL; California Department of Public Health, Richmond, California, USA., Barbaduomo CM; California Department of Public Health, Richmond, California, USA., Dong ZN; California Department of Public Health, Richmond, California, USA., Fang AT; California Department of Public Health, Richmond, California, USA., Frost PM; California Department of Public Health, Richmond, California, USA., Ho T; California Department of Public Health, Richmond, California, USA., Javadi MH; California Department of Public Health, Richmond, California, USA., Li SS; California Department of Public Health, Richmond, California, USA., Tran VH; California Department of Public Health, Richmond, California, USA., Wan C; California Department of Public Health, Richmond, California, USA., Jain S; California Department of Public Health, Richmond, California, USA., Lewnard JA; Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, USA.; Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, California, USA.; Center for Computational Biology, College of Engineering, University of California, Berkeley, California, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Aug 24; Vol. 75 (1), pp. e276-e288.